PNC Financial Services Group Inc. Has $199,000 Stake in U.S. Physical Therapy, Inc. $USPH

PNC Financial Services Group Inc. trimmed its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 40.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,746 shares of the company’s stock after selling 1,859 shares during the period. PNC Financial Services Group Inc.’s holdings in U.S. Physical Therapy were worth $199,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Portside Wealth Group LLC raised its holdings in shares of U.S. Physical Therapy by 3.9% during the first quarter. Portside Wealth Group LLC now owns 4,108 shares of the company’s stock worth $297,000 after acquiring an additional 154 shares during the period. Precision Wealth Strategies LLC raised its holdings in shares of U.S. Physical Therapy by 6.6% during the first quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company’s stock worth $221,000 after acquiring an additional 189 shares during the period. Aquatic Capital Management LLC raised its holdings in shares of U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock worth $115,000 after acquiring an additional 198 shares during the period. Bessemer Group Inc. raised its holdings in shares of U.S. Physical Therapy by 4.4% during the first quarter. Bessemer Group Inc. now owns 4,929 shares of the company’s stock worth $357,000 after acquiring an additional 208 shares during the period. Finally, Albert D Mason Inc. raised its holdings in shares of U.S. Physical Therapy by 2.5% during the first quarter. Albert D Mason Inc. now owns 10,856 shares of the company’s stock worth $786,000 after acquiring an additional 260 shares during the period.

U.S. Physical Therapy Trading Down 0.3%

USPH opened at $85.72 on Monday. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.19. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of 37.43, a PEG ratio of 4.38 and a beta of 1.45. The company’s 50 day moving average price is $77.56 and its two-hundred day moving average price is $76.87.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. During the same period in the previous year, the firm posted $0.73 EPS. The company’s revenue for the quarter was up 18.0% compared to the same quarter last year. As a group, research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy’s payout ratio is presently 78.60%.

Insider Buying and Selling

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,792 shares of the business’s stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $86.57, for a total transaction of $155,133.44. Following the sale, the chief operating officer directly owned 22,246 shares of the company’s stock, valued at $1,925,836.22. The trade was a 7.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Nancy Ham sold 400 shares of the business’s stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the sale, the director directly owned 2,594 shares in the company, valued at $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Barrington Research raised their target price on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a research report on Friday, August 8th. Zacks Research upgraded shares of U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th. JMP Securities reiterated a “market outperform” rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Wall Street Zen upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $110.25.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.